ProShare Advisors LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.8% during the third quarter, Holdings Channel reports. The firm owned 225,898 shares of the semiconductor company’s stock after buying an additional 8,358 shares during the quarter. ProShare Advisors LLC’s holdings in Synopsys were worth $98,252,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the stock. Elevation Wealth Partners LLC increased its position in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares during the period. Osbon Capital Management LLC purchased a new stake in Synopsys in the second quarter worth about $25,000. IMG Wealth Management Inc. purchased a new stake in Synopsys in the second quarter worth about $28,000. GK Wealth Management LLC purchased a new stake in Synopsys in the third quarter worth about $28,000. Finally, Geneos Wealth Management Inc. boosted its position in Synopsys by 151.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 50 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on SNPS shares. Wells Fargo & Company upped their target price on Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Morgan Stanley raised their target price on Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research note on Tuesday, October 20th. Rothschild & Co Redburn dropped their price target on Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Mizuho reduced their price target on Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research note on Thursday, August 27th. Finally, Sanford C. Bernstein assumed coverage on Synopsys in a research note on Friday, September 25th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $575.00.
Get Our Latest Analysis on Synopsys
Insider Buying and Selling
In related news, insider Janet Lee sold 1,144 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the sale, the insider owned 16,534 shares in the company, valued at $8,308,665.68. This represents a 6.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Aart de Geus sold 24,641 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares of the company’s stock, valued at approximately $50,518,611.92. This trade represents a 16.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $467.61 on Monday. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The firm has a 50-day moving average of $437.48 and a 200 day moving average of $443.62. The stock has a market cap of $89.61 billion, a P/E ratio of 82.62, a price-to-earnings-growth ratio of 1.90 and a beta of 1.18.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. During the same quarter in the prior year, the company earned $3.39 earnings per share. The business’s revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.
Synopsys declared that its board has initiated a stock repurchase program on Monday, October 5th that authorizes the company to repurchase $1 billion in outstanding shares. This repurchase authorization authorizes the semiconductor company to buy up to 1.1% of its stock through open market purchases. Share repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.
Synopsys Company Profile
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
Featured Articles
- Five stocks we like better than Synopsys
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
